针对质母细胞瘤的酶向疗法
Maria Salbini1, Alessia Formato1, Maria Patrizia Mongiardi1
1Institute of Biochemistry and Cell Biology, National Research Council, Via Ercole Ramarini 32, Monterotondo, 00015 Rome, Italy.
International journal of molecular sciences
|May 7, 2025
概括
激酶抑制剂对于治疗致命的脑癌质母细胞瘤至关重要. 本综述审查了这些向治疗的历史和发展,针对质母细胞瘤患者.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 通过酶和酶对蛋白质酸化调节细胞功能.
- 失调的激酶活性与癌症,特别是质母细胞瘤有关.
- 受体氨酸激酶 (RTK) 路径突变在质母细胞瘤中很常见.
研究的目的:
- 审查酶抑制剂药物在质母细胞瘤治疗中的历史.
- 突出针对性疗法在治疗这种侵袭性脑瘤中的作用.
主要方法:
- 关于激酶抑制剂和质母细胞瘤治疗的文献综述.
- 对药物开发和批准的历史数据的分析.
- 检查质母细胞瘤中涉及的信号通路.
主要成果:
- 激酶抑制剂代表了质母细胞瘤治疗的重大进步.
- 多酶抑制剂Regorafenib最近获得了治疗质母细胞瘤的批准.
- 向疗法旨在解决RTK路径失调的问题.
结论:
- 激酶抑制剂已发展成为质母细胞瘤的重要治疗策略.
- 对激酶抑制剂机制和组合的进一步研究是有必要的.
- 了解这些药物的历史将为未来的质母细胞瘤治疗方法提供信息.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


